Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
07 2021
Historique:
received: 15 09 2020
revised: 28 10 2020
accepted: 18 11 2020
pubmed: 28 11 2020
medline: 13 10 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

To investigate corneal stiffness parameters (SPs) as predictors of future progression risk in glaucoma suspect eyes. Prospective, longitudinal study. Three hundred seventy-one eyes from 228 primary open-angle glaucoma suspects, based on optic disc appearance, with normal baseline Humphrey Visual Field (HVF; Carl Zeiss Meditec) results. Baseline corneal SPs were measured using Corvis ST (Oculus Optikgeräte GmbH). Participants were followed up every 6 months with clinical examination, HVF testing, and OCT. The baseline SP at first applanation (SP-A1) and highest concavity predicted the prospective outcome measures. Structural progression was measured by the OCT rate of thinning of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL). Functional progression was assessed by permutation analysis of pointwise linear regression criteria on HVF testing. Stiffness parameters correlated positively with central corneal thickness (CCT), which was adjusted for in all analyses. A higher SP-A1, suggestive of a stiffer cornea, was associated with a faster rate of RNFL thinning (P < 0.001), synergistic with thinner CCT (P = 0.004) over a mean follow-up of 4.2 years. Eyes with higher SP-A1 and thinner CCT (thin and stiff corneas) showed accelerated RNFL thinning by 0.72 μm/year relative to eyes with lower SP-A1 and thicker CCT (95% confidence interval [CI], 0.17-1.28; P = 0.011) and were at 2.9-fold higher likelihood of fast RNFL progression of more than 1 μm/year (95% CI, 1.4-6.1; P = 0.006). Consistent results also were observed with GCIPL thinning. Furthermore, a higher SP-A1 was associated with a greater risk of visual field progression (P = 0.002), synergistic with thinner CCT (P = 0.010). Eyes with higher SP-A1 and thinner CCT were at 3.7-fold greater risk of visual field progression relative to eyes with thicker CCT and lower SP-A1 (95% CI, 1.3-10.5; P = 0.014). Glaucoma suspect eyes with higher corneal SPs and lower CCT, suggestive of thin and stiff corneas, are at greater risk of progression. Corneal SPs seem to act synergistically with CCT as risk factors for glaucoma progression.

Identifiants

pubmed: 33245936
pii: S0161-6420(20)31116-7
doi: 10.1016/j.ophtha.2020.11.021
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

993-1004

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. All rights reserved.

Auteurs

Ayub Qassim (A)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia. Electronic address: ayub.qassim@flinders.edu.au.

Sean Mullany (S)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Farshad Abedi (F)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Henry Marshall (H)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Mark M Hassall (MM)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Antonia Kolovos (A)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Lachlan S W Knight (LSW)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Thi Nguyen (T)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Mona S Awadalla (MS)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Angela Chappell (A)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Angela M Schulz (AM)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Anna Galanopoulos (A)

South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, Australia.

Ashish Agar (A)

Department of Ophthalmology, Prince of Wales Hospital, Randwick, Australia.

Paul R Healey (PR)

Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.

Alex W Hewitt (AW)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Stuart L Graham (SL)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

John Landers (J)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Robert J Casson (RJ)

South Australian Institute of Ophthalmology, University of Adelaide, Adelaide, Australia.

Owen M Siggs (OM)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Jamie E Craig (JE)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH